Airtraq Versus Conventional Laryngoscopy in Children

University Hospitals Bristol and Weston NHS Foundation Trust60 enrolled

Overview

The investigators aim to compare the new paediatric Airtraq indirect optical laryngoscope with conventional direct laryngoscopy for tracheal intubation in a randomised crossover study during routine anaesthesia. The investigators hypothesise that the Airtraq is as good as conventional laryngoscopy for tracheal intubation of infants and children. This will be an equivalence rather than a non-inferiority study.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

NONE

Enrollment

Conditions

Children General Anesthesia Intubation

Interventions

Airtraq laryngoscopyDEVICE

laryngoscopy and intubation

Eligibility

Sex: ALLMax age: 6 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All children less than 6 years of age, in whom a size 2.5 - 5.5 tracheal tube would be considered suitable. * Classified by the American Society of Anesthesiology (ASA) as grade 1-3. * Scheduled for surgery under general anaesthesia, and in whom tracheal intubation and neuromuscular blocking drugs are planned to be used. Exclusion Criteria: * inability of patient or parents to understand the study or consent process * known or suspected difficult airway * ASA 4 and above

Locations (1)

Bristol Childrens hospital

Bristol, Bristol, United Kingdom

Outcomes

Primary Outcomes

time taken to successful intubation

The primary outcome measure will be time taken to successful intubation. This will be recorded by a second operator using a handheld stopwatch or wall clock with second hand. Time will commence when the intubation device is handed to the anaesthetist, and stopped after the first successful inflation of the lungs (first upstroke of capnography trace).

Time frame: 30 mins

Secondary Outcomes

Grade of laryngoscopy

Time frame: 30 mins

POGO score

Time frame: 30 mins

VAS ease of intubation

Time frame: 30 mins

evidence of traumatic intubation

Time frame: 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.